| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.637 | 0.003 | 0.637 | Dopamine D5 antagonist | 0.338 0.004 DBMET03192 0.565 0.003 DBMET03193 0.292 0.004 DBMET03197 0.293 0.004 DBMET03194 0.255 0.004 DBMET03195 0.175 0.005 DBMET03196 | ||
| 0.555 | 0.005 | 0.555 | Dopamine D2 antagonist | 0.211 0.016 DBMET03192 0.348 0.009 DBMET03193 0.173 0.019 DBMET03194 0.066 0.046 DBMET03195 | ||
| 0.527 | 0.005 | 0.527 | Dopamine antagonist | 0.197 0.019 DBMET03192 0.309 0.011 DBMET03193 0.165 0.023 DBMET03194 0.068 0.056 DBMET03195 0.062 0.061 DBMET03196 | ||
| 0.424 | 0.105 | 0.424 | Alpha-glucosidase inhibitor | 0.24 0.193 DBMET03192 0.395 0.117 DBMET03193 0.33 0.145 DBMET03197 0.332 0.145 DBMET03195 0.317 0.151 DBMET03196 | ||
| 0.302 | 0.005 | 0.302 | Dopamine D3 antagonist | 0.086 0.03 DBMET03192 0.161 0.014 DBMET03193 0.061 0.044 DBMET03194 | ||
| 0.299 | 0.012 | 0.299 | Anesthetic local | 0.178 0.038 DBMET03192 0.162 0.044 DBMET03193 0.113 0.072 DBMET03197 0.099 0.084 DBMET03195 | ||
| 0.272 | 0.017 | 0.272 | 5 Hydroxytryptamine 2B antagonist | 0.162 0.036 DBMET03192 0.176 0.032 DBMET03193 0.145 0.043 DBMET03197 0.112 0.068 DBMET03194 0.098 0.085 DBMET03195 | ||
| 0.307 | 0.062 | 0.307 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.195 0.103 DBMET03193 0.225 0.087 DBMET03197 | ||
| 0.241 | 0.01 | 0.241 | Dopamine D4 antagonist | 0.064 0.04 DBMET03192 0.14 0.019 DBMET03193 0.072 0.036 DBMET03194 | ||
| 0.23 | 0.009 | 0.23 | Dopamine D1 antagonist | 0.092 0.028 DBMET03192 0.111 0.022 DBMET03193 0.062 0.048 DBMET03197 0.065 0.044 DBMET03194 0.068 0.041 DBMET03195 0.056 0.055 DBMET03196 | ||
| 0.27 | 0.073 | 0.27 | Ca(v)3.3 blocker | 0.251 0.099 DBMET03192 0.224 0.144 DBMET03193 0.217 0.158 DBMET03194 | ||
| 0.343 | 0.158 | 0.412 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.374 0.125 DBMET03193 0.374 0.125 DBMET03197 0.265 0.264 DBMET03194 0.412 0.09 DBMET03195 0.304 0.207 DBMET03196 | DBMET03195 | |
| 0.182 | 0.013 | 0.428 | Aminoacyl-tRNA synthetase inhibitor | 0.245 0.008 DBMET03192 0.178 0.013 DBMET03193 0.428 0.004 DBMET03197 0.234 0.009 DBMET03194 0.187 0.012 DBMET03195 0.241 0.009 DBMET03196 | DBMET03197 | |
| 0.22 | 0.07 | 0.22 | Psychostimulant | 0.152 0.115 DBMET03192 0.194 0.083 DBMET03193 0.156 0.111 DBMET03197 0.174 0.097 DBMET03194 0.184 0.09 DBMET03195 0.156 0.111 DBMET03196 | ||
| 0.286 | 0.14 | 0.328 | Beta lactamase inhibitor | 0.328 0.123 DBMET03193 0.242 0.16 DBMET03195 | DBMET03193 | |
| 0.131 | 0.008 | 0.131 | Nicotinic receptor alpha7 subunit antagonist | 0.091 0.014 DBMET03192 0.067 0.023 DBMET03193 0.059 0.03 DBMET03194 | ||
| 0.162 | 0.04 | 0.162 | 5 Hydroxytryptamine 2 antagonist | 0.136 0.05 DBMET03192 0.125 0.055 DBMET03193 0.091 0.079 DBMET03197 | ||
| 0.125 | 0.006 | 0.125 | Orexin receptor antagonist | 0.073 0.036 DBMET03192 0.109 0.009 DBMET03193 0.073 0.037 DBMET03194 | ||
| 0.142 | 0.024 | 0.182 | Alpha 2a adrenoreceptor antagonist | 0.182 0.016 DBMET03192 0.073 0.055 DBMET03193 0.074 0.053 DBMET03197 0.073 0.054 DBMET03194 | DBMET03192 | |
| 0.11 | 0.009 | 0.11 | Orexin receptor 1 antagonist | 0.073 0.047 DBMET03192 0.101 0.012 DBMET03193 0.074 0.045 DBMET03194 | ||
| 0.252 | 0.155 | 0.252 | Antiobesity | 0.207 0.2 DBMET03192 | ||
| 0.213 | 0.117 | 0.293 | 5 Hydroxytryptamine 1E antagonist | 0.236 0.09 DBMET03192 0.293 0.034 DBMET03197 0.175 0.16 DBMET03194 | DBMET03197 | |
| 0.113 | 0.02 | 0.137 | Neuronal nicotinic receptor antagonist | 0.137 0.014 DBMET03192 0.059 0.055 DBMET03193 0.078 0.038 DBMET03194 | DBMET03192 | |
| 0.121 | 0.03 | 0.139 | Acetylcholine nicotinic antagonist | 0.139 0.024 DBMET03192 0.075 0.061 DBMET03194 | DBMET03192 | |
| 0.087 | 0.004 | 0.087 | Glucose-6-phosphate dehydrogenase inhibitor | 0.06 0.007 DBMET03192 0.072 0.005 DBMET03193 0.055 0.009 DBMET03194 0.035 0.033 DBMET03195 | ||
| 0.093 | 0.014 | 0.093 | Potassium channel (Tandem pore domain) blocker | 0.078 0.04 DBMET03192 | ||
| 0.269 | 0.196 | 0.395 | Apoptosis agonist | 0.344 0.142 DBMET03197 0.395 0.116 DBMET03196 | DBMET03196 | |
| 0.194 | 0.125 | 0.194 | Spasmolytic | |||
| 0.188 | 0.131 | 0.256 | Cardiotonic | 0.256 0.078 DBMET03193 0.169 0.153 DBMET03194 | DBMET03193 | |
| 0.081 | 0.026 | 0.125 | 5 Hydroxytryptamine 2A agonist | 0.12 0.009 DBMET03192 0.066 0.041 DBMET03193 0.125 0.008 DBMET03197 0.081 0.027 DBMET03194 0.063 0.043 DBMET03196 | DBMET03197 | |
| 0.122 | 0.068 | 0.122 | Acetylcholine antagonist | 0.117 0.073 DBMET03192 0.11 0.08 DBMET03193 | ||
| 0.123 | 0.071 | 0.123 | Cholinergic antagonist | 0.117 0.076 DBMET03192 0.11 0.083 DBMET03193 | ||
| 0.096 | 0.048 | 0.115 | 5 Hydroxytryptamine 2C antagonist | 0.115 0.038 DBMET03192 | DBMET03192 | |
| 0.115 | 0.068 | 0.115 | 5 Hydroxytryptamine antagonist | 0.092 0.087 DBMET03192 | ||
| 0.122 | 0.076 | 0.122 | Papain-like protease (SARS coronavirus) inhibitor | 0.119 0.085 DBMET03192 0.113 0.101 DBMET03193 0.117 0.089 DBMET03194 0.118 0.087 DBMET03195 0.122 0.076 DBMET03196 | ||
| 0.178 | 0.133 | 0.275 | Nitric-oxide synthase stimulant | 0.233 0.046 DBMET03192 0.189 0.109 DBMET03193 0.275 0.019 DBMET03197 0.246 0.035 DBMET03194 0.189 0.109 DBMET03195 0.246 0.035 DBMET03196 | DBMET03197 | |
| 0.096 | 0.051 | 0.115 | Alpha 2 adrenoreceptor antagonist | 0.115 0.039 DBMET03192 | DBMET03192 | |
| 0.049 | 0.007 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET03192 | ||
| 0.088 | 0.048 | 0.088 | Opioid kappa receptor antagonist | |||
| 0.061 | 0.023 | 0.061 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.112 | 0.075 | 0.14 | Transcription factor STAT6 inhibitor | 0.14 0.032 DBMET03197 | DBMET03197 | |
| 0.191 | 0.153 | 0.274 | Tyrosine 3 hydroxylase inhibitor | 0.265 0.055 DBMET03192 0.274 0.048 DBMET03197 0.183 0.168 DBMET03194 0.186 0.163 DBMET03196 | DBMET03197 | |
| 0.076 | 0.041 | 0.076 | Phospholipase D inhibitor | |||
| 0.039 | 0.004 | 0.039 | 5 Hydroxytryptamine 4 agonist | 0.033 0.005 DBMET03192 0.024 0.017 DBMET03193 | ||
| 0.045 | 0.012 | 0.305 | Melanocortin 5 antagonist | 0.282 0.003 DBMET03192 0.036 0.013 DBMET03193 0.305 0.003 DBMET03194 | DBMET03194 | |
| 0.089 | 0.057 | 0.089 | Opioid antagonist | |||
| 0.097 | 0.066 | 0.124 | Glutamate (mGluR7) agonist | 0.103 0.054 DBMET03192 0.124 0.026 DBMET03193 0.117 0.033 DBMET03197 0.106 0.049 DBMET03194 | DBMET03193 | |
| 0.046 | 0.016 | 0.046 | Orexin receptor 2 antagonist | 0.042 0.019 DBMET03193 | ||
| 0.184 | 0.161 | 0.368 | Transcription factor STAT inhibitor | 0.368 0.028 DBMET03197 | DBMET03197 | |
| 0.032 | 0.009 | 0.077 | Follicle-stimulating hormone agonist | 0.03 0.01 DBMET03192 0.062 0.005 DBMET03193 0.077 0.004 DBMET03197 0.037 0.008 DBMET03194 0.028 0.011 DBMET03195 0.025 0.013 DBMET03196 | DBMET03197 | |
| 0.07 | 0.049 | 0.098 | HIV-1 reverse transcriptase inhibitor | 0.098 0.032 DBMET03197 | DBMET03197 | |
| 0.05 | 0.029 | 0.276 | Melanocortin antagonist | 0.185 0.007 DBMET03192 0.053 0.027 DBMET03193 0.276 0.005 DBMET03194 | DBMET03194 | |
| 0.054 | 0.034 | 0.09 | 5 Hydroxytryptamine 2 agonist | 0.09 0.012 DBMET03192 0.079 0.016 DBMET03197 0.045 0.043 DBMET03194 | DBMET03192 | |
| 0.047 | 0.028 | 0.047 | Baculoviral IAP repeat-containing protein inhibitor | |||
| 0.225 | 0.208 | 0.475 | DNA directed DNA polymerase inhibitor | 0.34 0.142 DBMET03197 0.393 0.118 DBMET03195 0.475 0.09 DBMET03196 | DBMET03196 | |
| 0.195 | 0.179 | 0.211 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.193 0.185 DBMET03192 0.211 0.137 DBMET03195 0.195 0.181 DBMET03196 | DBMET03195 | |
| 0.018 | 0.005 | 0.037 | Antibiotic Tetracycline-like | 0.02 0.004 DBMET03192 0.018 0.005 DBMET03193 0.037 0.001 DBMET03197 0.02 0.004 DBMET03194 0.019 0.005 DBMET03195 0.02 0.004 DBMET03196 | DBMET03197 | |
| 0.021 | 0.008 | 0.023 | Complement factor D inhibitor | 0.022 0.006 DBMET03192 0.023 0.005 DBMET03197 | DBMET03197 | |
| 0.185 | 0.173 | 0.276 | MAP kinase kinase 3 inhibitor | 0.276 0.014 DBMET03197 0.207 0.104 DBMET03195 | DBMET03197 | |
| 0.028 | 0.018 | 0.028 | Sigma 2 receptor antagonist | |||
| 0.08 | 0.072 | 0.08 | Alpha adrenoreceptor antagonist | 0.076 0.075 DBMET03192 | ||
| 0.086 | 0.079 | 0.086 | Alpha 2c adrenoreceptor antagonist | |||
| 0.05 | 0.044 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | 0.063 0.023 DBMET03192 | DBMET03192 | |
| 0.024 | 0.017 | 0.095 | Protein 30S ribosomal subunit inhibitor | 0.034 0.011 DBMET03192 0.022 0.02 DBMET03193 0.095 0.003 DBMET03197 0.027 0.015 DBMET03194 0.022 0.019 DBMET03195 0.027 0.014 DBMET03196 | DBMET03197 | |
| 0.028 | 0.024 | 0.028 | Potassium channel subfamily K member 3 blocker | |||
| 0.045 | 0.042 | 0.045 | Dopamine D4 agonist | |||
| 0.024 | 0.02 | 0.024 | Sigma 1 receptor antagonist | |||
| 0.181 | 0.178 | 0.288 | Hypoxia-inducible factor 1 alpha inhibitor | 0.288 0.071 DBMET03197 0.22 0.13 DBMET03196 | DBMET03197 | |
| 0.013 | 0.01 | 0.017 | Melatonin receptor 1A antagonist | 0.017 0.007 DBMET03192 0.015 0.008 DBMET03194 | DBMET03192 | |
| 0.049 | 0.046 | 0.071 | Alpha-mannosidase inhibitor | 0.071 0.016 DBMET03192 0.053 0.038 DBMET03194 | DBMET03192 | |
| 0.078 | 0.076 | 0.079 | 3C-Like protease (SARS coronavirus) inhibitor | 0.079 0.072 DBMET03192 0.078 0.074 DBMET03193 | DBMET03192 | |
| 0.055 | 0.055 | 0.092 | Ryanodine receptor antagonist | 0.067 0.022 DBMET03192 0.092 0.005 DBMET03197 0.065 0.025 DBMET03194 0.056 0.051 DBMET03195 0.075 0.013 DBMET03196 | DBMET03197 | |
| 0.024 | 0.025 | 0.035 | Melatonin antagonist | 0.033 0.014 DBMET03192 0.035 0.012 DBMET03194 | DBMET03194 | |
| 0.05 | 0.053 | 0.069 | 5 Hydroxytryptamine 7 agonist | 0.055 0.041 DBMET03193 0.069 0.02 DBMET03197 | DBMET03197 | |
| 0.05 | 0.055 | 0.053 | Acetylcholine M2 receptor antagonist | 0.053 0.051 DBMET03193 | DBMET03193 | |
| 0.16 | 0.173 | 0.309 | RNA-directed DNA polymerase inhibitor | 0.309 0.03 DBMET03197 0.186 0.121 DBMET03195 0.182 0.128 DBMET03196 | DBMET03197 | |
| 0.043 | 0.057 | 0.098 | Antiviral (Hepatitis D) | 0.081 0.008 DBMET03192 0.098 0.005 DBMET03194 | DBMET03194 | |
| 0.051 | 0.065 | 0.087 | 5 Hydroxytryptamine agonist | 0.087 0.038 DBMET03192 | DBMET03192 | |
| 0.175 | 0.191 | 0.266 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.266 0.092 DBMET03197 | DBMET03197 | |
| 0.204 | 0.222 | 0.423 | DNA polymerase beta inhibitor | 0.375 0.129 DBMET03197 0.36 0.135 DBMET03195 0.423 0.11 DBMET03196 | DBMET03196 | |
| 0.044 | 0.062 | 0.091 | Potassium channel Kv1.5 blocker | 0.052 0.046 DBMET03192 0.091 0.022 DBMET03193 0.086 0.023 DBMET03194 | DBMET03193 | |
| 0.153 | 0.174 | 0.228 | ErbB-1 antagonist | 0.19 0.101 DBMET03192 0.228 0.065 DBMET03197 | DBMET03197 | |
| 0.077 | 0.1 | 0.091 | Falcipain 3 inhibitor | 0.091 0.08 DBMET03197 | DBMET03197 | |
| 0.165 | 0.189 | 0.297 | 12-Lipoxygenase inhibitor | 0.297 0.081 DBMET03197 0.225 0.126 DBMET03195 0.199 0.153 DBMET03196 | DBMET03197 | |
| 0.115 | 0.14 | 0.164 | Sphingosine 1-phosphate receptor 5 antagonist | 0.164 0.041 DBMET03197 | DBMET03197 | |
| 0.013 | 0.04 | 0.021 | Progesterone receptor B antagonist | 0.021 0.011 DBMET03197 | DBMET03197 | |
| 0.032 | 0.059 | 0.056 | Mannosidase inhibitor | 0.056 0.02 DBMET03192 0.041 0.038 DBMET03194 | DBMET03192 | |
| 0.035 | 0.065 | 0.044 | Alpha 1L adrenoreceptor agonist | 0.044 0.027 DBMET03192 0.043 0.029 DBMET03197 | DBMET03192 | |
| 0.02 | 0.052 | 0.041 | Cyclophilin A inhibitor | 0.028 0.026 DBMET03197 0.041 0.011 DBMET03194 | DBMET03194 | |
| 0.092 | 0.126 | 0.132 | Cathepsin H inhibitor | 0.132 0.061 DBMET03197 | DBMET03197 | |
| 0.124 | 0.158 | 0.157 | Heat shock protein 70 antagonist | 0.157 0.032 DBMET03197 | DBMET03197 | |
| 0.041 | 0.079 | 0.053 | Epithelial sodium channel blocker | 0.053 0.041 DBMET03197 | DBMET03197 | |
| 0.081 | 0.119 | 0.211 | Amylase inhibitor | 0.108 0.089 DBMET03192 0.211 0.04 DBMET03197 | DBMET03197 | |
| 0.019 | 0.06 | 0.046 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.046 0.013 DBMET03197 | DBMET03197 | |
| 0.158 | 0.203 | 0.204 | Thyroid hormone antagonist | 0.204 0.159 DBMET03195 | DBMET03195 | |
| 0.027 | 0.076 | 0.038 | Histone deacetylase 9 inhibitor | 0.038 0.029 DBMET03194 | DBMET03194 | |
| 0.017 | 0.073 | 0.064 | 5 Hydroxytryptamine 2C agonist | 0.064 0.018 DBMET03192 | DBMET03192 | |
| 0.017 | 0.074 | 0.06 | Purinergic P2X7 antagonist | 0.06 0.01 DBMET03193 | DBMET03193 | |
| 0.187 | 0.246 | 0.44 | Antibacterial | 0.295 0.139 DBMET03192 0.383 0.085 DBMET03197 0.327 0.116 DBMET03194 0.407 0.074 DBMET03195 0.44 0.06 DBMET03196 | DBMET03196 | |
| 0.147 | 0.208 | 0.186 | Thyroid hormone beta antagonist | 0.186 0.168 DBMET03195 | DBMET03195 | |
| 0.043 | 0.106 | 0.116 | Sirtuin 1 inhibitor | 0.116 0.016 DBMET03197 | DBMET03197 | |
| 0.046 | 0.11 | 0.082 | Nicotinic alpha4beta2 receptor antagonist | 0.082 0.048 DBMET03192 | DBMET03192 | |
| 0.166 | 0.239 | 0.233 | Sodium/bile acid cotransporter inhibitor | 0.226 0.155 DBMET03197 0.218 0.164 DBMET03194 0.214 0.169 DBMET03195 0.233 0.147 DBMET03196 | DBMET03196 | |
| 0.143 | 0.216 | 0.281 | Peptidyltransferase inhibitor | 0.281 0.033 DBMET03197 0.172 0.142 DBMET03196 | DBMET03197 | |
| 0.016 | 0.09 | 0.041 | Melanocortin 4 antagonist | 0.041 0.03 DBMET03194 | DBMET03194 | |
| 0.146 | 0.219 | 0.306 | Transcription factor STAT3 inhibitor | 0.178 0.168 DBMET03192 0.306 0.05 DBMET03197 | DBMET03197 | |
| 0.096 | 0.171 | 0.152 | Sphingosine 1-phosphate receptor 2 antagonist | 0.152 0.038 DBMET03197 | DBMET03197 | |
| 0.068 | 0.146 | 0.108 | Carbonic anhydrase XV inhibitor | 0.108 0.057 DBMET03197 | DBMET03197 | |
| 0.024 | 0.104 | 0.058 | Phenylethanolamine N methyltransferase inhibitor | 0.058 0.009 DBMET03192 | DBMET03192 | |
| 0.029 | 0.111 | 0.065 | Glutamate (mGluR group III) antagonist | 0.065 0.011 DBMET03197 | DBMET03197 | |
| 0.03 | 0.114 | 0.052 | Nicotinic receptor alpha4 subunit antagonist | 0.052 0.029 DBMET03192 | DBMET03192 | |
| 0.01 | 0.094 | 0.03 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.017 DBMET03192 | DBMET03192 | |
| 0.024 | 0.11 | 0.042 | Plasmepsin II inhibitor | 0.042 0.027 DBMET03197 | DBMET03197 | |
| 0.043 | 0.129 | 0.125 | Glutamate (mGluR7) antagonist | 0.125 0.004 DBMET03197 | DBMET03197 | |
| 0.027 | 0.115 | 0.048 | Glutamate (mGluR4) antagonist | 0.048 0.023 DBMET03197 | DBMET03197 | |
| 0.005 | 0.093 | 0.102 | Growth hormone secretagogue receptor agonist | 0.102 0.006 DBMET03192 0.048 0.019 DBMET03194 | DBMET03192 | |
| 0.044 | 0.132 | 0.106 | Acetylcholine M3 receptor agonist | 0.106 0.042 DBMET03193 | DBMET03193 | |
| 0.02 | 0.109 | 0.059 | Alpha 1d adrenoreceptor antagonist | 0.059 0.042 DBMET03197 | DBMET03197 | |
| 0.053 | 0.148 | 0.117 | Sphingomyelinase inhibitor | 0.083 0.082 DBMET03192 0.117 0.043 DBMET03197 | DBMET03197 | |
| 0.034 | 0.13 | 0.217 | Histidine decarboxylase inhibitor | 0.217 0.011 DBMET03197 | DBMET03197 | |
| 0.022 | 0.119 | 0.075 | Purinergic P2X antagonist | 0.075 0.015 DBMET03193 | DBMET03193 | |
| 0.032 | 0.132 | 0.064 | Bombesin 1 receptor agonist | 0.064 0.037 DBMET03194 | DBMET03194 | |
| 0.19 | 0.291 | 0.447 | Calcium channel L-type activator | 0.262 0.193 DBMET03192 0.38 0.095 DBMET03193 0.447 0.052 DBMET03194 0.37 0.103 DBMET03195 0.383 0.093 DBMET03196 | DBMET03194 | |
| 0.058 | 0.16 | 0.095 | mTOR complex 2 inhibitor | 0.095 0.04 DBMET03197 | DBMET03197 | |
| 0.057 | 0.166 | 0.096 | Polo-like kinase-1 inhibitor | 0.096 0.051 DBMET03197 | DBMET03197 | |
| 0.088 | 0.198 | 0.136 | Thiol protease inhibitor | 0.123 0.111 DBMET03192 0.136 0.086 DBMET03197 0.124 0.109 DBMET03194 | DBMET03197 | |
| 0.043 | 0.171 | 0.103 | Carbonic anhydrase VI inhibitor | 0.103 0.037 DBMET03197 | DBMET03197 | |
| 0.049 | 0.181 | 0.1 | Breast cancer-resistant protein inhibitor | 0.1 0.055 DBMET03197 | DBMET03197 | |
| 0.022 | 0.156 | 0.086 | Purinergic P2X2 antagonist | 0.086 0.037 DBMET03197 | DBMET03197 | |
| 0.046 | 0.181 | 0.153 | Expectorant | 0.153 0.034 DBMET03197 | DBMET03197 | |
| 0.072 | 0.208 | 0.173 | Protein-tyrosine phosphatase inhibitor | 0.133 0.098 DBMET03192 0.173 0.06 DBMET03197 0.126 0.107 DBMET03194 | DBMET03197 | |
| 0.079 | 0.218 | 0.331 | Heat shock protein 90 antagonist | 0.331 0.007 DBMET03197 | DBMET03197 | |
| 0.052 | 0.192 | 0.184 | Tubulin antagonist | 0.184 0.042 DBMET03197 | DBMET03197 | |
| 0.139 | 0.28 | 0.202 | Insulysin inhibitor | 0.202 0.154 DBMET03192 0.195 0.164 DBMET03197 0.193 0.168 DBMET03194 | DBMET03192 | |
| 0.055 | 0.203 | 0.157 | Mucolytic | 0.157 0.028 DBMET03197 | DBMET03197 | |
| 0.034 | 0.184 | 0.079 | Insulin like growth factor 1 antagonist | 0.079 0.062 DBMET03197 | DBMET03197 | |
| 0.03 | 0.181 | 0.062 | ZAP-70 protein tyrosine kinase inhibitor | 0.062 0.058 DBMET03197 | DBMET03197 | |
| 0.077 | 0.232 | 0.111 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.071 DBMET03193 0.11 0.074 DBMET03195 | DBMET03193 | |
| 0.023 | 0.179 | 0.197 | CXC chemokine 4 receptor antagonist | 0.197 0.011 DBMET03192 0.151 0.015 DBMET03194 | DBMET03192 | |
| 0.024 | 0.183 | 0.083 | Cyclin D1 inhibitor | 0.083 0.016 DBMET03197 | DBMET03197 | |
| 0.032 | 0.193 | 0.083 | Insulin growth factor antagonist | 0.083 0.063 DBMET03197 | DBMET03197 | |
| 0.018 | 0.181 | 0.04 | 5 Hydroxytryptamine 2B agonist | 0.04 0.024 DBMET03197 | DBMET03197 | |
| 0.098 | 0.262 | 0.191 | Calpain inhibitor | 0.191 0.122 DBMET03193 0.184 0.129 DBMET03197 0.183 0.131 DBMET03194 | DBMET03193 | |
| 0.017 | 0.184 | 0.071 | Somatostatin 4 agonist | 0.071 0.01 DBMET03192 0.042 0.02 DBMET03194 | DBMET03192 | |
| 0.136 | 0.304 | 0.291 | Transcription factor inhibitor | 0.291 0.16 DBMET03197 0.239 0.194 DBMET03195 0.268 0.175 DBMET03196 | DBMET03197 | |
| 0.082 | 0.251 | 0.167 | P-glycoprotein inhibitor | 0.167 0.093 DBMET03196 | DBMET03196 | |
| 0.038 | 0.208 | 0.149 | Urease inhibitor | 0.149 0.024 DBMET03197 | DBMET03197 | |
| 0.01 | 0.181 | 0.022 | ICAM 1 antagonist | 0.022 0.018 DBMET03197 | DBMET03197 | |
| 0.032 | 0.214 | 0.095 | Protein-tyrosine phosphatase 1B inhibitor | 0.095 0.083 DBMET03197 | DBMET03197 | |
| 0.048 | 0.23 | 0.121 | Epidermal growth factor receptor kinase inhibitor | 0.121 0.072 DBMET03197 | DBMET03197 | |
| 0.02 | 0.209 | 0.078 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.078 0.004 DBMET03197 | DBMET03197 | |
| 0.008 | 0.197 | 0.056 | Estradiol 17 beta-dehydrogenase inhibitor | 0.056 0.022 DBMET03197 | DBMET03197 | |
| 0.02 | 0.213 | 0.045 | Kainate receptor agonist | 0.045 0.021 DBMET03197 | DBMET03197 | |
| 0.048 | 0.241 | 0.106 | Granulocyte macrophage colony stimulating factor agonist | 0.106 0.027 DBMET03197 | DBMET03197 | |
| 0.029 | 0.224 | 0.095 | Protease 3C (Human rhinovirus) inhibitor | 0.095 0.018 DBMET03197 | DBMET03197 | |
| 0.079 | 0.278 | 0.203 | Tumour necrosis factor antagonist | 0.203 0.052 DBMET03197 | DBMET03197 | |
| 0.063 | 0.264 | 0.14 | Phospholipase A2 inhibitor | 0.14 0.085 DBMET03197 | DBMET03197 | |
| 0.068 | 0.274 | 0.224 | DNA methyltransferase I inhibitor | 0.131 0.129 DBMET03192 0.224 0.058 DBMET03197 | DBMET03197 | |
| 0.039 | 0.247 | 0.11 | UDP-glucose 4-epimerase inhibitor | 0.11 0.051 DBMET03197 | DBMET03197 | |
| 0.026 | 0.238 | 0.041 | Heme oxygenase inhibitor | 0.041 0.038 DBMET03197 | DBMET03197 | |
| 0.014 | 0.227 | 0.035 | Hedgehog signaling activator | 0.035 0.007 DBMET03197 | DBMET03197 | |
| 0.064 | 0.277 | 0.119 | Sphingosine 1-phosphate receptor 4 antagonist | 0.119 0.075 DBMET03197 | DBMET03197 | |
| 0.022 | 0.238 | 0.095 | Glutamate decarboxylase inhibitor | 0.095 0.032 DBMET03197 | DBMET03197 | |
| 0.028 | 0.247 | 0.157 | Potassium channel (Ca-activated) activator | 0.157 0.026 DBMET03197 | DBMET03197 | |
| 0.057 | 0.277 | 0.221 | Histone deacetylase SIRT1 inhibitor | 0.221 0.024 DBMET03197 0.145 0.066 DBMET03194 | DBMET03197 | |
| 0.031 | 0.254 | 0.083 | Potassium channel large-conductance Ca-activated activator | 0.083 0.033 DBMET03197 | DBMET03197 | |
| 0.065 | 0.291 | 0.173 | Interleukin agonist | 0.173 0.146 DBMET03194 | DBMET03194 | |
| 0.094 | 0.323 | 0.143 | Neurotensin receptor agonist | 0.143 0.12 DBMET03197 | DBMET03197 | |
| 0.076 | 0.308 | 0.274 | Streptokinase A inhibitor | 0.274 0.09 DBMET03197 | DBMET03197 | |
| 0.036 | 0.271 | 0.101 | Uric acid excretion stimulant | 0.101 0.052 DBMET03197 | DBMET03197 | |
| 0.012 | 0.247 | 0.025 | Complement factor 1s inhibitor | 0.025 0.017 DBMET03197 | DBMET03197 | |
| 0.033 | 0.27 | 0.103 | Glycine receptor agonist | 0.103 0.019 DBMET03197 | DBMET03197 | |
| 0.014 | 0.252 | 0.046 | Poly(ADP-ribose) polymerase inhibitor | 0.046 0.029 DBMET03197 | DBMET03197 | |
| 0.011 | 0.251 | 0.035 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.035 0.03 DBMET03197 | DBMET03197 | |
| 0.046 | 0.289 | 0.099 | Microtubule formation inhibitor | 0.099 0.093 DBMET03197 | DBMET03197 | |
| 0.097 | 0.34 | 0.234 | Angiogenesis inhibitor | 0.234 0.135 DBMET03197 | DBMET03197 | |
| 0.061 | 0.307 | 0.205 | Antimitotic | 0.205 0.081 DBMET03197 | DBMET03197 | |
| 0.049 | 0.295 | 0.363 | Angiogenesis stimulant | 0.155 0.119 DBMET03195 0.363 0.029 DBMET03196 | DBMET03196 | |
| 0.111 | 0.361 | 0.179 | MAP kinase kinase 5 inhibitor | 0.179 0.065 DBMET03197 | DBMET03197 | |
| 0.046 | 0.297 | 0.171 | Activin receptor-like kinase 2 inhibitor | 0.171 0.052 DBMET03197 | DBMET03197 | |
| 0.015 | 0.267 | 0.068 | Purinergic P2 antagonist | 0.068 0.04 DBMET03193 | DBMET03193 | |
| 0.005 | 0.257 | 0.108 | Sirtuin 2 inhibitor | 0.108 0.004 DBMET03197 | DBMET03197 | |
| 0.095 | 0.348 | 0.141 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.12 DBMET03196 | DBMET03196 | |
| 0.063 | 0.318 | 0.27 | DNA methylase inhibitor | 0.27 0.038 DBMET03197 | DBMET03197 | |
| 0.053 | 0.308 | 0.129 | Dual specificity phosphatase inhibitor | 0.129 0.123 DBMET03197 | DBMET03197 | |
| 0.049 | 0.308 | 0.15 | Dual specificity phosphatase 3 inhibitor | 0.15 0.097 DBMET03197 | DBMET03197 | |
| 0.014 | 0.276 | 0.087 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.087 0.021 DBMET03197 | DBMET03197 | |
| 0.021 | 0.284 | 0.04 | CF transmembrane conductance regulator antagonist | 0.04 0.027 DBMET03196 | DBMET03196 | |
| 0.052 | 0.315 | 0.135 | MAP3K9 inhibitor | 0.135 0.086 DBMET03195 0.128 0.099 DBMET03196 | DBMET03195 | |
| 0.116 | 0.38 | 0.258 | Caspase 3 stimulant | 0.258 0.105 DBMET03197 | DBMET03197 | |
| 0.078 | 0.341 | 0.148 | ATPase inhibitor | 0.148 0.104 DBMET03197 | DBMET03197 | |
| 0.097 | 0.362 | 0.311 | 15-Lipoxygenase inhibitor | 0.311 0.125 DBMET03197 | DBMET03197 | |
| 0.016 | 0.282 | 0.208 | Histone deacetylase SIRT2 inhibitor | 0.208 0.005 DBMET03197 | DBMET03197 | |
| 0.071 | 0.337 | 0.152 | Interferon gamma antagonist | 0.152 0.075 DBMET03197 | DBMET03197 | |
| 0.066 | 0.333 | 0.188 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.188 0.082 DBMET03197 | DBMET03197 | |
| 0.048 | 0.318 | 0.089 | Hematopoietic | 0.089 0.051 DBMET03194 | DBMET03194 | |
| 0.054 | 0.325 | 0.121 | Aurora-C kinase inhibitor | 0.121 0.103 DBMET03192 | DBMET03192 | |
| 0.045 | 0.317 | 0.151 | DOPA decarboxylase inhibitor | 0.151 0.021 DBMET03197 | DBMET03197 | |
| 0.053 | 0.324 | 0.289 | Heat shock protein 90 alpha antagonist | 0.289 0.016 DBMET03197 | DBMET03197 | |
| 0.029 | 0.304 | 0.225 | Adenine nucleotide translocase inhibitor | 0.225 0.002 DBMET03195 0.067 0.018 DBMET03196 | DBMET03195 | |
| 0.051 | 0.327 | 0.271 | I kappa B kinase epsilon inhibitor | 0.271 0.027 DBMET03197 | DBMET03197 | |
| 0.014 | 0.291 | 0.049 | Adenylate cyclase 1 inhibitor | 0.049 0.027 DBMET03197 | DBMET03197 | |
| 0.048 | 0.326 | 0.138 | TRPA1 agonist | 0.138 0.041 DBMET03197 | DBMET03197 | |
| 0.015 | 0.297 | 0.125 | CXC chemokine receptor antagonist | 0.089 0.031 DBMET03192 0.125 0.016 DBMET03194 | DBMET03194 | |
| 0.067 | 0.349 | 0.181 | Succinate dehydrogenase inhibitor | 0.181 0.066 DBMET03197 | DBMET03197 | |
| 0.008 | 0.293 | 0.042 | Urokinase inhibitor | 0.042 0.037 DBMET03197 | DBMET03197 | |
| 0.031 | 0.316 | 0.098 | 5 Hydroxytryptamine 3A agonist | 0.098 0.078 DBMET03197 | DBMET03197 | |
| 0.017 | 0.302 | 0.065 | Carbonic anhydrase VA inhibitor | 0.065 0.052 DBMET03197 | DBMET03197 | |
| 0.008 | 0.299 | 0.084 | Prostaglandin EP2 antagonist | 0.084 0.025 DBMET03193 | DBMET03193 | |
| 0.08 | 0.376 | 0.194 | Histone acetyltransferase inhibitor | 0.194 0.078 DBMET03197 | DBMET03197 | |
| 0.141 | 0.437 | 0.335 | Caspase 9 stimulant | 0.335 0.158 DBMET03197 | DBMET03197 | |
| 0.036 | 0.335 | 0.188 | Neurotrophic factor | 0.188 0.033 DBMET03195 0.174 0.041 DBMET03196 | DBMET03195 | |
| 0.031 | 0.332 | 0.237 | Histone deacetylase class III inhibitor | 0.237 0.011 DBMET03197 0.099 0.091 DBMET03194 | DBMET03197 | |
| 0.034 | 0.337 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.076 DBMET03197 | DBMET03197 | |
| 0.004 | 0.311 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 DBMET03197 | DBMET03197 | |
| 0.057 | 0.364 | 0.127 | GABA C receptor rho-2 antagonist | 0.127 0.11 DBMET03197 | DBMET03197 | |
| 0.037 | 0.346 | 0.379 | Pyruvate kinase inhibitor | 0.379 0.025 DBMET03197 | DBMET03197 | |
| 0.014 | 0.326 | 0.091 | Sphingosine 1-phosphate receptor 4 agonist | 0.091 0.03 DBMET03197 | DBMET03197 | |
| 0.035 | 0.348 | 0.081 | MAP kinase kinase 7 inhibitor | 0.081 0.042 DBMET03197 | DBMET03197 | |
| 0.013 | 0.328 | 0.058 | Carbonic anhydrase V inhibitor | 0.058 0.056 DBMET03197 | DBMET03197 | |
| 0.02 | 0.336 | 0.093 | Heat shock protein 90 beta antagonist | 0.093 0.014 DBMET03197 | DBMET03197 | |
| 0.013 | 0.334 | 0.12 | Monophenol monooxygenase inhibitor | 0.12 0.062 DBMET03197 | DBMET03197 | |
| 0.007 | 0.331 | 0.171 | Antineoplastic antibiotic | 0.085 0.054 DBMET03195 0.171 0.026 DBMET03196 | DBMET03196 | |
| 0.029 | 0.356 | 0.056 | Immunoglobulin Fc receptor antagonist | 0.056 0.035 DBMET03197 | DBMET03197 | |
| 0.041 | 0.37 | 0.258 | MAP kinase kinase 2 inhibitor | 0.258 0.05 DBMET03197 | DBMET03197 | |
| 0.006 | 0.336 | 0.051 | Inosine monophosphate dehydrogenase inhibitor | 0.051 0.014 DBMET03197 | DBMET03197 | |
| 0.008 | 0.338 | 0.089 | MAO B inhibitor | 0.089 0.066 DBMET03197 | DBMET03197 | |
| 0.026 | 0.358 | 0.062 | Histone deacetylase SIRT3 inhibitor | 0.062 0.042 DBMET03197 | DBMET03197 | |
| 0.058 | 0.39 | 0.282 | 3C-like protease (Human coronavirus) inhibitor | 0.282 0.016 DBMET03197 | DBMET03197 | |
| 0.099 | 0.433 | 0.311 | Calcium channel activator | 0.311 0.081 DBMET03197 0.21 0.198 DBMET03194 | DBMET03197 | |
| 0.036 | 0.371 | 0.065 | MDM2 inhibitor | 0.065 0.056 DBMET03197 | DBMET03197 | |
| 0.028 | 0.375 | 0.087 | Glutamate (mGluR6) antagonist | 0.087 0.018 DBMET03197 | DBMET03197 | |
| 0.016 | 0.364 | 0.111 | MAO inhibitor | 0.111 0.08 DBMET03197 | DBMET03197 | |
| 0.093 | 0.443 | 0.244 | GABA C receptor rho-3 antagonist | 0.244 0.159 DBMET03197 | DBMET03197 | |
| 0.04 | 0.39 | 0.118 | D-Ala-D-Ala ligase inhibitor | 0.118 0.014 DBMET03197 | DBMET03197 | |
| 0.029 | 0.381 | 0.126 | GABA C receptor rho-1 antagonist | 0.126 0.035 DBMET03197 | DBMET03197 | |
| 0.004 | 0.357 | 0.021 | Somatostatin 2 agonist | 0.021 0.006 DBMET03192 | DBMET03192 | |
| 0.067 | 0.42 | 0.195 | Superoxide dismutase inhibitor | 0.195 0.123 DBMET03197 | DBMET03197 | |
| 0.008 | 0.364 | 0.031 | Somatostatin agonist | 0.031 0.022 DBMET03192 | DBMET03192 | |
| 0.012 | 0.37 | 0.255 | Check point kinase 2 inhibitor | 0.082 0.081 DBMET03192 0.255 0.009 DBMET03197 | DBMET03197 | |
| 0.018 | 0.376 | 0.087 | GABA aminotransferase inhibitor | 0.087 0.038 DBMET03197 | DBMET03197 | |
| 0.028 | 0.388 | 0.087 | GABA B receptor agonist | 0.087 0.03 DBMET03197 | DBMET03197 | |
| 0.024 | 0.384 | 0.087 | Ferrochelatase inhibitor | 0.087 0.086 DBMET03197 | DBMET03197 | |
| 0.075 | 0.436 | 0.274 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.274 0.033 DBMET03197 0.154 0.141 DBMET03196 | DBMET03197 | |
| 0.035 | 0.419 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.104 0.092 DBMET03197 | DBMET03197 | |
| 0.014 | 0.399 | 0.054 | Dopamine beta hydroxylase inhibitor | 0.054 0.024 DBMET03197 | DBMET03197 | |
| 0.025 | 0.412 | 0.143 | Alkaline phosphatase inhibitor | 0.143 0.065 DBMET03197 | DBMET03197 | |
| 0.022 | 0.409 | 0.081 | Glutamate dehydrogenase inhibitor | 0.081 0.044 DBMET03197 | DBMET03197 | |
| 0.038 | 0.43 | 0.163 | Peroxidase inhibitor | 0.163 0.071 DBMET03197 | DBMET03197 | |
| 0.016 | 0.417 | 0.054 | Heparanase inhibitor | 0.054 0.035 DBMET03197 | DBMET03197 | |
| 0.025 | 0.428 | 0.106 | HIV-1 integrase (Overall Integration) inhibitor | 0.106 0.049 DBMET03197 | DBMET03197 | |
| 0.024 | 0.437 | 0.104 | Beta glucuronidase inhibitor | 0.104 0.064 DBMET03197 | DBMET03197 | |
| 0.042 | 0.457 | 0.15 | Hexokinase inhibitor | 0.15 0.079 DBMET03197 | DBMET03197 | |
| 0.094 | 0.511 | 0.298 | Interleukin 2 agonist | 0.298 0.075 DBMET03194 0.206 0.178 DBMET03196 | DBMET03194 | |
| 0.102 | 0.524 | 0.258 | 5 Hydroxytryptamine uptake stimulant | 0.258 0.073 DBMET03197 | DBMET03197 | |
| 0.014 | 0.443 | 0.073 | Aryl hydrocarbon receptor antagonist | 0.073 0.034 DBMET03197 | DBMET03197 | |
| 0.019 | 0.468 | 0.112 | GABA C receptor agonist | 0.112 0.055 DBMET03197 | DBMET03197 | |
| 0.028 | 0.482 | 0.333 | DNA polymerase I inhibitor | 0.333 0.009 DBMET03196 | DBMET03196 | |
| 0.021 | 0.476 | 0.097 | Exportin-1 inhibitor | 0.097 0.011 DBMET03197 | DBMET03197 | |
| 0.011 | 0.47 | 0.073 | CYP2A6 inhibitor | 0.073 0.056 DBMET03197 | DBMET03197 | |
| 0.007 | 0.466 | 0.062 | Biliverdin reductase inhibitor | 0.062 0.038 DBMET03197 | DBMET03197 | |
| 0.059 | 0.523 | 0.129 | MAP kinase kinase 4 inhibitor | 0.129 0.119 DBMET03197 | DBMET03197 | |
| 0.004 | 0.474 | 0.04 | Protein kinase (CK1) epsilon inhibitor | 0.04 0.025 DBMET03197 | DBMET03197 | |
| 0.024 | 0.496 | 0.161 | Mannose-6-phosphate isomerase inhibitor | 0.161 0.056 DBMET03197 | DBMET03197 | |
| 0.041 | 0.518 | 0.165 | Focal adhesion kinase 2 inhibitor | 0.165 0.107 DBMET03197 | DBMET03197 | |
| 0.016 | 0.503 | 0.093 | Cystathionine beta-synthase inhibitor | 0.093 0.086 DBMET03197 | DBMET03197 | |
| 0.041 | 0.536 | 0.217 | Transcription factor NF kappa B inhibitor | 0.193 0.176 DBMET03197 0.217 0.153 DBMET03196 | DBMET03196 | |
| 0.015 | 0.516 | 0.113 | GABA C receptor antagonist | 0.113 0.06 DBMET03197 | DBMET03197 | |
| 0.005 | 0.513 | 0.098 | Protein kinase (CK2) alpha inhibitor | 0.098 0.078 DBMET03197 | DBMET03197 | |
| 0.017 | 0.528 | 0.099 | Glutathione S-transferase inhibitor | 0.099 0.039 DBMET03197 | DBMET03197 | |
| 0.028 | 0.538 | 0.105 | Photosensitizer | 0.105 0.079 DBMET03197 | DBMET03197 | |
| 0.039 | 0.551 | 0.188 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.188 0.026 DBMET03197 | DBMET03197 | |
| 0.013 | 0.533 | 0.135 | MAP kinase kinase 1 inhibitor | 0.135 0.024 DBMET03197 | DBMET03197 | |
| 0.025 | 0.545 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.04 DBMET03197 | DBMET03197 | |
| 0.019 | 0.542 | 0.15 | Death-associated protein kinase 3 inhibitor | 0.15 0.122 DBMET03197 | DBMET03197 | |
| 0.003 | 0.54 | 0.042 | Fructose-1,6-bisphosphatase inhibitor | 0.042 0.036 DBMET03197 | DBMET03197 | |
| 0.011 | 0.55 | 0.106 | MAP kinase kinase inhibitor | 0.106 0.088 DBMET03197 | DBMET03197 | |
| 0.067 | 0.621 | 0.425 | 5 Hydroxytryptamine release inhibitor | 0.425 0.063 DBMET03197 | DBMET03197 | |
| 0.009 | 0.573 | 0.073 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.073 0.051 DBMET03197 | DBMET03197 | |
| 0.009 | 0.582 | 0.095 | Alcohol dehydrogenase inhibitor | 0.095 0.058 DBMET03197 | DBMET03197 | |
| 0.039 | 0.627 | 0.203 | Histamine release inhibitor | 0.203 0.198 DBMET03197 | DBMET03197 | |
| 0.022 | 0.623 | 0.14 | Non-steroidal antiinflammatory agent | 0.14 0.131 DBMET03197 | DBMET03197 | |
| 0.042 | 0.643 | 0.163 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.163 0.127 DBMET03197 | DBMET03197 | |
| 0.009 | 0.635 | 0.332 | Aryl hydrocarbon receptor agonist | 0.332 0.052 DBMET03197 | DBMET03197 | |
| 0.032 | 0.659 | 0.119 | DNA repair enzyme inhibitor | 0.119 0.074 DBMET03197 | DBMET03197 | |
| 0.006 | 0.681 | 0.148 | LIM domain kinase 1 inhibitor | 0.148 0.1 DBMET03197 | DBMET03197 | |
| 0.025 | 0.731 | 0.176 | CF transmembrane conductance regulator agonist | 0.176 0.04 DBMET03197 | DBMET03197 | |
| 0.019 | 0.749 | 0.151 | Phospholipase C inhibitor | 0.151 0.103 DBMET03197 | DBMET03197 | |
| 0.011 | 0.753 | 0.134 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.134 0.089 DBMET03197 | DBMET03197 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |